Section Arrow
CODX.NASDAQ
- Co-Diagnostics
(Financial Status)
Quotes are at least 15-min delayed:2025/08/25 16:58 EDT
After Hours
Last
 0.3167
0 (0.00%)
Bid
0.31
Ask
0.3104
High 0.3167 
Low 0.3104 
Volume 334 
Regular Hours
Last
 0.3167
-0.0022 (-0.69%)
Day High 
0.3299 
Prev. Close
0.3189 
1-M High
0.38 
Volume 
497.19K 
Bid
0.31
Ask
0.3104
Day Low
0.306001 
Open
0.3093 
1-M Low
0.235 
Market Cap 
10.75M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.28 
20-SMA 0.27 
50-SMA 0.27 
52-W High 1.92 
52-W Low 0.2275 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.15/-0.45
Enterprise Value
11.99M
Balance Sheet
Book Value Per Share
1.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.81M
Operating Revenue Per Share
0.22
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.4899-0.0101-2.02%-- 
After Hours 0.6114 +0.1215 +24.80%
DXCMDexCom75.96-6.3-7.66%57.93PE
After Hours 76.12 +0.16 +0.21%
BFLYButterfly Network1.55+0.03+1.97%-- 
After Hours 1.6 +0.05 +3.23%
MDTMedtronic plc92.04-0.67-0.72%25.68PE
After Hours 92.04 0 0.00%
ABTAbbott Laboratories131.87-0.72-0.54%16.64PE
After Hours 131.87 0 0.00%
Quotes are at least 15-min delayed:2025/08/25 16:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.